
Improving Alpha: The Public-Private Debate & Its Impact on Allocators
Why are companies like SpaceX, Anthropic, and OpenAI delaying going public, and can this phenomenon be traced back to regulatory changes of the nineties? Can private market funding essentially dry up, leaving no alternative? How do these firms approach regulatory thresholds and what is the impact to stratgeic allocations by today’s leading LPs? Michael Ewens, …








